Literature DB >> 28718069

Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study.

Juan Ambrosioni1, Francisca Artigues2, David Nicolás1, Judit Peñafiel1, Fernando Agüero3, Christian Manzardo1, María Mar Mosquera4, Sonsoles Sánchez-Palomino5, Elisa De Lazzari1, María A Marcos4, Montserrat Plana5, José M Miró6.   

Abstract

Primary HIV-1 infection is a relevant period for its virological and epidemiological consequences. Most patients present a symptomatic disease that can be potentially serious, but neurological involvement during primary HIV-1 infection has been poorly studied. The aim of this study was to describe the characteristics and outcomes of primary HIV-1 infection patients presenting neurological symptoms and to compare them with primary HIV-1 infection patients without neurological involvement. Retrospective case-control study (1:3) comparing primary HIV-1 infection patients with and without neurological involvement enrolled in the Acute/Recent Hospital Clinic PHI Cohort between 1997 and 2016. Matching criteria included age (±10 years), gender, year of diagnosis (±4 years), and Fiebig stage. The conditional logit model was used for comparisons. Fourteen out of 463 patients (3.02%) enrolled in the Acute/Recent Hospital Clinic PHI Cohort between 1997 and 2016 presented neurological symptoms. 28.5% of cases presented as meningitis and 71.5% as meningoencephalitis. Cerebrospinal fluid showed non-specific findings, including pleocytosis with lymphocyte predominance and increased protein levels. All cases required hospitalisation, whereas only 19% of the controls did. No other pathogen was identified in any case, but five patients initiated empirically antimicrobial treatment for other aetiologies until diagnosis was confirmed. CD4/CD8 ratio was significantly lower (p = 0.039) and plasmatic viral load significantly higher in the case group, compared to controls (p = 0.028). Risk factors, HIV-1 tropism, subtype distribution, and prescribed ART regimens were comparable between cases and controls. After 6 months on ART, 92% of cases had undetectable viral load, similar to controls, and CD4/CD8 ratio became also comparable between groups. All cases recovered rapidly with ART and were discharged without sequels. Neurological involvement during primary HIV-1 infection is unusual but serious, always requiring hospitalisation. Diagnosis is difficult because of the wide range of symptoms and similarities with other viral aetiologies. Neurological manifestations during primary HIV-1 infection are associated with a lower CD4/CD8 ratio and with a higher viral load than controls. Immediate ART initiation and rapid viral load decrease are required, allowing complete clinical recovery.

Entities:  

Keywords:  ART; CD4/CD8 ratio; Meningitis; Meningoencephalitis; Neurological involvement; PHI; Primary HIV infection; Viral load

Mesh:

Substances:

Year:  2017        PMID: 28718069     DOI: 10.1007/s13365-017-0548-6

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  18 in total

1.  CROI 2015: Neurologic Complications of HIV Infection.

Authors:  Serena S Spudich; Beau M Ances
Journal:  Top Antivir Med       Date:  2015 Mar-Apr

Review 2.  HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Authors:  Melissa J Churchill; Daniel J Cowley; Steve L Wesselingh; Paul R Gorry; Lachlan R Gray
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

3.  HIV-associated neurocognitive disorders: Five new things.

Authors:  Jeffrey A Rumbaugh; William Tyor
Journal:  Neurol Clin Pract       Date:  2015-06

4.  Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.

Authors:  G Tambussi; A Gori; B Capiluppi; C Balotta; L Papagno; B Morandini; M Di Pietro; D Ciuffreda; A Saracco; A Lazzarin
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

Review 5.  Neurologic complications of HIV disease and their treatment.

Authors:  Scott L Letendre; Ronald J Ellis; Beau M Ances; J Allen McCutchan
Journal:  Top HIV Med       Date:  2010 Apr-May

Review 6.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

Review 7.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

Review 8.  Movement disorders and AIDS: a review.

Authors:  Winona Tse; Maria G Cersosimo; Jean-Michel Gracies; Susan Morgello; C Warren Olanow; William Koller
Journal:  Parkinsonism Relat Disord       Date:  2004-08       Impact factor: 4.891

9.  Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up.

Authors:  S Villar del Saz; O Sued; V Falcó; F Agüero; M Crespo; T Pumarola; A Curran; J M Gatell; A Pahissa; J M Miró; E Ribera
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

10.  Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).

Authors:  Juan Ambrosioni; Omar Sued; David Nicolas; Marta Parera; María López-Diéguez; Anabel Romero; Fernando Agüero; María Ángeles Marcos; Christian Manzardo; Laura Zamora; Manuel Gómez-Carrillo; José María Gatell; Tomás Pumarola; José María Miró
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.